Molecular basis of Canavan's disease: from human to mouse.

about

Localisation of N-acetylaspartate in oligodendrocytes/myelin Genome-wide gene expression profiling and mutation analysis of Saudi patients with Canavan disease.Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination.

P2860

Q28304873-81D34C51-F95A-4654-B2B0-FBB9DC778E74 Q38359413-9B9C5CAC-B465-4BD1-AD6C-551ED2DB3634 Q41900843-D0B271C0-776D-4249-BDA1-2035132AC17A

P2860

Molecular basis of Canavan's disease: from human to mouse.

Item

http://www.wikidata.org/entity/Q35565452

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Molecular basis of Canavan's disease: from human to mouse.

@ast

Molecular basis of Canavan's disease: from human to mouse.

@en

type

Item

label

Molecular basis of Canavan's disease: from human to mouse.

@ast

Molecular basis of Canavan's disease: from human to mouse.

@en

prefLabel

Molecular basis of Canavan's disease: from human to mouse.

@ast

Molecular basis of Canavan's disease: from human to mouse.

@en

P1476

Molecular basis of Canavan's disease: from human to mouse.

@en

P2093

Kimberlee M Matalon

http://www.w3.org/2001/XMLSchema#string

Reuben Matalon

http://www.w3.org/2001/XMLSchema#string

Sankar Surendran

http://www.w3.org/2001/XMLSchema#string

Stephen K Tyring

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease

Molecular water pumps and the aetiology of Canavan disease: a case of the sorcerer's apprentice.

SPONGY DEGENERATION OF THE NERVOUS SYSTEM. A REPORT OF FOUR CASES WITH A REVIEW OF THE LITERATURE.

Implications of apoptotic cell death regulation in cancer therapy.

Transfer of genes to humans: early lessons and obstacles to success.

Herpes simplex virus vectors for gene therapy.

Gene transfer by adeno-associated virus vectors into the central nervous system.

Two novel aspartoacylase gene (ASPA) missense mutations specific to Norwegian and Swedish patients with Canavan disease.

In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy.

Aspartoacylase gene transfer to the mammalian central nervous system with therapeutic implications for Canavan disease.

P304

604-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/08830738030180090601

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240303447

http://www.w3.org/2001/XMLSchema#string

P698

14572138

http://www.w3.org/2001/XMLSchema#string

Molecular basis of Canavan's disease: from human to mouse.

about

P2860

P2860

Molecular basis of Canavan's disease: from human to mouse.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698